Insulin glargine and lixisenatide Subcutaneous and Tranexamic acid Intravenous
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Tranexamic acid Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: tranexamic acid
Brand name: Cyklokapron, Lysteda
Synonyms: Tranexamic acid, Tranexamic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Tranexamic Acid Tablet
- Insulin glargine and lixisenatide Subcutaneous-Tranexamic Acid Tablets
- Insulin glargine and lixisenatide Subcutaneous-Tranquil
- Insulin glargine and lixisenatide Subcutaneous-Transanosil
- Insulin glargine and lixisenatide Subcutaneous-Transderm-Nitro
- Insulin glargine and lixisenatide Subcutaneous-Transderm-Scop
- Tranexamic acid Intravenous-Insulin glargine, recombinant Subcutaneous
- Tranexamic acid Intravenous-Insulin glulisine
- Tranexamic acid Intravenous-Insulin Glulisine (Cartridges and Pens)
- Tranexamic acid Intravenous-Insulin Glulisine (Vials)
- Tranexamic acid Intravenous-Insulin glulisine Subcutaneous
- Tranexamic acid Intravenous-Insulin human inhaled Inhalation